REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 79 filers reported holding REPLIMUNE GROUP INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $432,055 | -66.2% | 18,607 | -74.3% | 0.00% | -80.0% |
| Q1 2023 | $1,277,048 | -39.0% | 72,313 | -6.0% | 0.01% | -37.5% |
| Q4 2022 | $2,093,312 | +281.3% | 76,960 | +144.8% | 0.01% | +166.7% |
| Q2 2022 | $549,000 | -25.0% | 31,434 | -27.1% | 0.00% | 0.0% |
| Q1 2022 | $732,000 | -50.4% | 43,110 | +12.2% | 0.00% | -50.0% |
| Q2 2021 | $1,476,000 | +36.4% | 38,421 | +8.4% | 0.01% | 0.0% |
| Q1 2021 | $1,082,000 | -59.8% | 35,452 | -49.7% | 0.01% | -70.0% |
| Q4 2020 | $2,690,000 | +277.8% | 70,522 | +128.0% | 0.02% | +100.0% |
| Q3 2020 | $712,000 | +22.5% | 30,931 | +32.4% | 0.01% | +11.1% |
| Q2 2020 | $581,000 | +5.6% | 23,363 | -57.6% | 0.01% | -35.7% |
| Q1 2020 | $550,000 | -56.7% | 55,125 | -37.8% | 0.01% | +75.0% |
| Q4 2019 | $1,271,000 | +319.5% | 88,583 | +306.4% | 0.01% | +166.7% |
| Q3 2019 | $303,000 | +27.8% | 21,799 | +34.6% | 0.00% | +50.0% |
| Q2 2019 | $237,000 | – | 16,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |